Skip to main content
Clinical Trials/DRKS00034500
DRKS00034500
Not yet recruiting
Not Applicable

Follow-up in oral squamous cell carcinoma – establishment of risk-adapted intervals

Klinikum Oldenburg0 sites800 target enrollmentJuly 15, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
C04.0
Sponsor
Klinikum Oldenburg
Enrollment
800
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 15, 2024
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Klinikum Oldenburg

Eligibility Criteria

Inclusion Criteria

  • Histologically confirmed PEC of the oral cavity (including tongue and anterior palatine arch), (ICD C00\.0 – C06\.9\)
  • \-Period 01\.03\.2018 – 31\.03\.2023
  • \-Initial diagnosis of PEC

Exclusion Criteria

  • \- Other tumor entities (e.g. salivary gland carcinomas, sarcomas, odontogenic tumors)
  • \- Recurrent carcinoma
  • \- Neoadjuvant pretreatment
  • \- M1 situation or inoperable situation
  • \- Tumor location outside the oral cavity
  • \- R1 – resected patients

Outcomes

Primary Outcomes

Not specified

Similar Trials